Consequently, there is an increase in the concentrations of p-SMAD2/3 and p-SMAD1/5, components of the transforming growth factor beta (TGF-β)/SMAD signaling pathway, which facilitates the growth, infiltration, and dissemination of skin cancer cells. The gene discussed is TGFB1; the disease is skin cancer.